ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,679Medicare Part D Prescriptions Filled, Including Refills

Rank: 145 out of 2588

$769K Total Retail Price of All Prescriptions

Rank: 181 out of 2588

547 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 547 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

19% of this provider’s 547 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 12,584 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
FUROSEMIDE 598 518 1 5
SIMVASTATIN 589 520 2 1
HYDROCODONE-ACETAMINOPHEN 497 381 S3 3 7
LEVOTHYROXINE SODIUM 489 435 4 2
LISINOPRIL 456 356 5 3
WARFARIN SODIUM 359 268 6 10
POTASSIUM CHLORIDE 343 308 7 15
OMEPRAZOLE 325 295 8 6
METOPROLOL TARTRATE 281 244 9 9
METFORMIN HCL 235 182 10 8
PANTOPRAZOLE SODIUM 222 197 11 28
DONEPEZIL HCL 217 210 12 22
AMLODIPINE BESYLATE 217 211 12 4
ATORVASTATIN CALCIUM 204 191 14 11
GLIMEPIRIDE 185 164 15 39
KLOR-CON M20 176 141 16 52
GABAPENTIN 174 147 17 18
HYDROCHLOROTHIAZIDE 174 170 17 13
ATENOLOL 174 160 17 14
NAMENDA 161 157 20 32
CITALOPRAM HBR 145 144 21 27
BYSTOLIC 145 145 21 110
ZOLPIDEM TARTRATE 143 116 23 24
NIASPAN 141 121 24 115
SERTRALINE HCL 137 116 25 26
SPIRONOLACTONE 135 119 26 58
CARVEDILOL 127 117 27 20
CLOPIDOGREL 124 109 28 30
RISPERIDONE 120 113 29 57
METHYLPREDNISOLONE 120 94 29 144
TRAMADOL HCL 118 105 31 19
ALLOPURINOL 114 96 32 33
MELOXICAM 110 88 33 51
TRIAMTERENE-HCTZ 108 84 34 46
TAMSULOSIN HCL 107 100 35 23
IBUPROFEN 106 94 36 62
LOVASTATIN 101 86 37 34
LANTUS 100 90 38 47
LEVOFLOXACIN 99 86 39 77
ISOSORBIDE MONONITRATE ER 97 87 40 49
PREDNISONE 96 82 41 42
ZETIA 92 72 42 69
PLAVIX 92 82 42 43
NITROGLYCERIN PATCH 91 79 44 149
OXYBUTYNIN CHLORIDE ER 89 60 45 85
AZITHROMYCIN 86 71 46 45
LEVETIRACETAM 83 69 47 90
FAMOTIDINE 79 67 48 36
NITROFURANTOIN MONO-MACRO 78 69 49 234
NIFEDIPINE ER 77 77 50 59
EXELON 77 77 50 118
LOSARTAN POTASSIUM 75 66 52 17
METOPROLOL SUCCINATE 74 65 53 12
DOXYCYCLINE HYCLATE 74 58 53 151
SPIRIVA 72 67 55 56
KLOR-CON 10 71 70 56 75
DIGOXIN 71 70 56 38
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 69 58 35
SYNTHROID 68 68 59 88
PAROXETINE HCL 68 68 59 71
DIOVAN 68 66 59 29
CARBIDOPA-LEVODOPA 67 67 62 83
AZOR 66 65 63 361
ACETAMINOPHEN-CODEINE 65 50 S3 64 80
NOVOLOG 62 53 65 103
ADVAIR DISKUS 61 44 66 48
CELEBREX 61 61 66 99
CRESTOR 60 46 68 25
GLIPIZIDE 59 55 69 44
QUETIAPINE FUMARATE 59 53 69 74
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 49 71 127
POLYETHYLENE GLYCOL 3350 56 41 71 55
ALENDRONATE SODIUM 55 43 73 21
ENALAPRIL MALEATE 51 50 74 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.